索利德生物科学 SLDB
$6.59 +$0.41 (+6.63%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $6.72 +1.97%
开盘$6.18
昨收$6.18
当日区间$6.18 – $6.73
成交量1.43M
市值$735.51M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$57.38M-37.6% YoY
净利润-$54.80M-38.8% YoY
摊薄每股收益-$0.38+9.5% YoY
自由现金流-$52.74M-39.6% YoY
经营现金流-$52.59M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-65.5%
资产收益率-56.8%
投入资本回报率-64.3%
流动比率13.82
负债/资产比率11.1%
现金及投资$377.68M
总负债$17.92M
净现金（净负债）$359.76M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $0.00 | $0.00 | – | – | $0.00 |
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $57.38M | $57.31M | $179.21M | $49.40M | $48.06M |
| 销售及管理费用 | $13.12M | $11.17M | $38.88M | $11.27M | $9.20M |
| -管理费用 | $13.12M | $11.17M | $38.88M | $11.27M | $9.20M |
| 研发费用 | $44.27M | $46.14M | $140.33M | $38.14M | $38.86M |
| 营业利润 | -$57.38M | -$57.31M | -$179.21M | -$49.40M | -$48.06M |
| 非经营性利息净收入（支出） | $3.22M | $2.06M | $10.11M | $2.05M | $2.92M |
| 非经营性利息收入 | $3.22M | $2.06M | $10.11M | $2.05M | $2.92M |
| 非经营性利息支出 | $0.00 | $0.00 | – | – | – |
| 其他收入（支出） | -$636,000.00 | -$1.49M | -$5.23M | -$2.43M | -$640,000.00 |
| 证券出售收益 | -$850,000.00 | -$1.65M | -$6.05M | -$2.65M | -$850,000.00 |
| 其他非经营性收入（支出） | $214,000.00 | $157,000.00 | $824,000.00 | $219,000.00 | $210,000.00 |
| 税前利润 | -$54.80M | -$56.74M | -$174.33M | -$49.79M | -$45.78M |
| 净利润 | -$54.80M | -$56.74M | -$174.33M | -$49.79M | -$45.78M |
| 持续经营利润 | -$54.80M | -$56.74M | -$174.33M | -$49.79M | -$45.78M |
| 归属母公司净利润 | -$54.80M | -$56.74M | -$174.33M | -$49.79M | -$45.78M |
| 归属普通股股东净利润 | -$54.80M | -$56.74M | -$174.33M | -$49.79M | -$45.78M |
| 基本每股收益 | -$0.38 | -$0.52 | -$1.99 | -$0.53 | -$0.48 |
| 摊薄每股收益 | -$0.38 | -$0.52 | -$1.99 | -$0.53 | -$0.48 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $420.58M | $422.89M | $232.54M | $232.54M | $273.91M |
| 流动资产合计 | $395.11M | $396.79M | $205.46M | $205.46M | $244.85M |
| 现金及现金等价物与短期投资 | $377.68M | $380.68M | $187.85M | $187.85M | $236.14M |
| -现金及现金等价物 | $159.39M | $297.10M | $59.90M | $59.90M | $61.36M |
| -短期投资 | $218.28M | $83.58M | $127.95M | $127.95M | $174.78M |
| 预付资产 | $13.86M | $12.49M | $13.97M | $13.97M | $5.60M |
| 受限现金 | $638,000.00 | $638,000.00 | $1.22M | $1.22M | – |
| 其他流动资产 | $2.93M | $2.98M | $2.42M | $2.42M | $3.11M |
| 非流动资产合计 | $25.47M | $26.11M | $27.08M | $27.08M | $29.06M |
| 固定资产净值 | $24.63M | $25.21M | $26.09M | $26.09M | $26.89M |
| -固定资产原值 | $24.63M | $25.21M | $40.28M | $40.28M | $26.89M |
| 其他非流动资产 | $846,000.00 | $891,000.00 | $991,000.00 | $991,000.00 | $2.17M |
| 负债合计 | $46.51M | $48.76M | $52.53M | $52.53M | $55.97M |
| 流动负债合计 | $28.58M | $30.28M | $33.47M | $33.47M | $36.34M |
| 应付款 | $4.36M | $5.56M | $3.22M | $3.22M | $8.43M |
| -应付账款 | $4.36M | $5.56M | $3.22M | $3.22M | $8.43M |
| 一年内应计费用 | $11.57M | $14.80M | $10.13M | $10.13M | $11.89M |
| 短期债务及融资租赁负债 | $2.23M | $2.19M | $2.10M | $2.10M | $2.31M |
| -一年内到期融资租赁负债 | $2.23M | $2.19M | $2.10M | $2.10M | $2.31M |
| 其他流动负债 | $4.20M | $3.35M | $9.20M | $9.20M | $6.55M |
| 非流动负债合计 | $17.92M | $18.48M | $19.06M | $19.06M | $19.62M |
| 长期债务及融资租赁负债 | $17.92M | $18.48M | $19.06M | $19.06M | $19.62M |
| -长期融资租赁负债 | $17.92M | $18.48M | $19.06M | $19.06M | $19.62M |
| 股东权益合计 | $374.08M | $374.13M | $180.01M | $180.01M | $217.95M |
| 股东权益 | $374.08M | $374.13M | $180.01M | $180.01M | $217.95M |
| 股本 | $105,000.00 | $98,000.00 | $79,000.00 | $79,000.00 | $78,000.00 |
| -普通股 | $105,000.00 | $98,000.00 | $79,000.00 | $79,000.00 | $78,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $1.44B | $1.39B | $1.14B | $1.14B | $1.13B |
| 留存收益 | -$1.07B | -$1.01B | -$957.78M | -$957.78M | -$907.99M |
| 不影响留存收益的损益 | -$113,000.00 | -$13,000.00 | $52,000.00 | $52,000.00 | $48,000.00 |
| -累计折旧 | – | – | -$14.19M | -$14.19M | – |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$52.59M | -$47.23M | -$156.29M | -$53.56M | -$33.47M |
| 持续经营经营活动现金流净额 | -$52.59M | -$47.23M | -$156.29M | -$53.56M | -$33.47M |
| 持续经营净利润 | -$54.80M | -$56.74M | -$174.33M | -$49.79M | -$45.78M |
| 持续经营损益 | $850,000.00 | $1.65M | $6.05M | $2.65M | $850,000.00 |
| 折旧、折耗与摊销 | $391,000.00 | $395,000.00 | $1.64M | $467,000.00 | $376,000.00 |
| 其他非现金项目 | $659,000.00 | $623,000.00 | $2.13M | $611,000.00 | $304,000.00 |
| 营运资金变动 | -$3.94M | $2.31M | -$6.82M | -$13.25M | $7.17M |
| -预付资产变动 | -$1.28M | $954,000.00 | -$7.99M | -$7.65M | $1.72M |
| -应付账款及应计费用变动 | -$2.15M | $1.85M | $2.96M | -$5.11M | $5.90M |
| -其他流动负债变动 | -$510,000.00 | -$496,000.00 | -$1.79M | -$495,000.00 | -$443,000.00 |
| 投资活动现金流净额 | -$133.59M | $44.76M | -$58.45M | $47.01M | -$45.27M |
| 持续经营投资活动现金流净额 | -$133.59M | $44.76M | -$58.45M | $47.01M | -$45.27M |
| 固定资产购置及出售净额 | -$150,000.00 | -$165,000.00 | -$1.07M | -$480,000.00 | -$85,000.00 |
| 投资购置及出售净额 | -$133.44M | $44.92M | -$57.39M | $47.58M | -$45.19M |
| 筹资活动现金流 | $48.47M | $239.03M | $194.45M | $5.14M | $1.18M |
| 持续经营筹资活动现金流净额 | $48.47M | $239.03M | $194.45M | $5.14M | $1.18M |
| 债务发行及偿还净额 | $0.00 | $0.00 | -$723,000.00 | -$203,000.00 | -$243,000.00 |
| 普通股发行净额 | $48.12M | $239.01M | $194.74M | $5.12M | $1.42M |
| 股票期权行使所得 | $351,000.00 | $18,000.00 | $431,000.00 | $229,000.00 | $0.00 |
| 期末现金余额 | $160.74M | $298.45M | $61.89M | $61.89M | $63.29M |
| 现金净变动 | -$137.71M | $236.56M | -$20.30M | -$1.40M | -$77.57M |
| 期初现金余额 | $298.45M | $61.89M | $82.19M | $63.29M | $140.86M |
| 自由现金流 | -$52.74M | -$47.40M | -$157.44M | -$54.12M | -$33.56M |
| 其他投资变动净额 | – | – | – | – | $0.00 |
暂无评论——快来第一个聊聊 SLDB。
登录后参与讨论。